BioSpace News Archive

The organization will surpass $145 million in lifetime funding celebrating its 20th Year in ‘Saving Lives and Creating Hope’ to End Childhood Cancer

Medicure Inc.. (“Medicure” or the “Company”) (TSXV:MPH, OTC:MCUJF), a cardiovascular pharmaceutical company, is pleased to announce that the Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (“ANDA”) for Sodium Nitroprusside Injection 50 mg/2 mL (25 mg/mL) single dose vial (“SNP”), a generic intravenous cardiovascular drug product.

Fast-growing Massage and Facial Services Franchise to Open 30th Houston Area Location in Fulshear on August 15

Health Canada is warning Canadians of the potential risk of cancer relapse in patients with cancer of the blood and lymph nodes who have undergone stem cell transplant and are taking long-term azithromycin (Zithromax).

The summit will feature experts from the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.

Orchard Therapeutics, a leading commercial-stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced the completion of an oversubscribed $150 million Series C financing.

Zelluna Immunotherapy, the biotechnology company specializing in T-cell receptor (TCR) immunotherapies targeting a broad range of solid cancers with a high unmet medical need, today announces the appointment of Dr. Namir Hassan as chief scientific officer (CSO).

Drivers, Helpers, Mechanics and Dispatchers Send Wake-Up Call to Company

BBI Solutions will showcase its pioneering lateral flow diagnostics technology as sponsor of the Next Generation Dx Summit in Washington later this month.

Company to Hold Conference Call and Webcast Today, Monday, August 13, 2018 at 4:30 PM EST-